These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18681110)

  • 1. Natriuretic peptides for guiding heart failure therapy.
    Rehman SU; Januzzi JL
    Compr Ther; 2008; 34(1):32-40. PubMed ID: 18681110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 4. Designer natriuretic peptides: a vision for the future of heart failure therapeutics.
    Zakeri R; Burnett JC
    Can J Physiol Pharmacol; 2011 Aug; 89(8):593-601. PubMed ID: 21815778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored therapy for heart failure: neurohormones.
    Richards AM
    Can J Physiol Pharmacol; 2011 Aug; 89(8):603-7. PubMed ID: 21812619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential for existing and novel forms of natriuretic peptides.
    Chen HH; Burnett JC
    Heart Fail Clin; 2006 Jul; 2(3):365-73. PubMed ID: 17386905
    [No Abstract]   [Full Text] [Related]  

  • 7. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
    Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides: novel therapeutic targets in heart failure.
    Cataliotti A; Burnett JC
    J Investig Med; 2005 Nov; 53(7):378-84. PubMed ID: 16297366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure.
    Krupicka J; Janota T; Kasalová Z; Hradec J
    Physiol Res; 2009; 58(2):171-177. PubMed ID: 18380534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern approach to the treatment of decompensated heart failure.
    Vilas-Boas F
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):159-67. PubMed ID: 19210212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovery and significance of natriuretic peptides].
    Nakao K; Tamura N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():5-9. PubMed ID: 15506327
    [No Abstract]   [Full Text] [Related]  

  • 13. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical biochemistry: heart hormones. The Danish Society of Biochemistry].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2004 Mar; 166(12):1109. PubMed ID: 15067768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.
    Ichiki T; Dzhoyashvili N; Burnett JC
    Int J Cardiol; 2019 Apr; 281():166-171. PubMed ID: 29941213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular biomarkers in the ICU.
    Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction.
    Richards AM
    Heart; 2009 Aug; 95(16):1299-300. PubMed ID: 19447834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.